Literature DB >> 8462657

The hematopoietic deficiencies in osteopetrotic (op/op) mice are not permanent, but progressively correct with age.

S K Begg, I Bertoncello.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8462657

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


× No keyword cloud information.
  6 in total

1.  Developmental and functional significance of the CSF-1 proteoglycan chondroitin sulfate chain.

Authors:  Sayan Nandi; Mohammed P Akhter; Mark F Seifert; Xu-Ming Dai; E Richard Stanley
Journal:  Blood       Date:  2005-10-06       Impact factor: 22.113

2.  Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation.

Authors:  Y Y Myint; K Miyakawa; M Naito; L D Shultz; Y Oike; K Yamamura; K Takahashi
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

Review 3.  Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor.

Authors:  Violeta Chitu; E Richard Stanley
Journal:  Curr Top Dev Biol       Date:  2016-12-01       Impact factor: 4.897

Review 4.  CSF1R as a Therapeutic Target in Bone Diseases: Obvious but Not so Simple.

Authors:  David A Hume; Lena Batoon; Anuj Sehgal; Sahar Keshvari; Katharine M Irvine
Journal:  Curr Osteoporos Rep       Date:  2022-10-05       Impact factor: 5.163

5.  Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors.

Authors:  F Arai; T Miyamoto; O Ohneda; T Inada; T Sudo; K Brasel; T Miyata; D M Anderson; T Suda
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

6.  Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.

Authors:  Guillaume Mabilleau; Afsie Sabokbar
Journal:  PLoS One       Date:  2009-01-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.